Addus HomeCare Corporation (NASDAQ:ADUS) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS) have earned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eight have given a buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $137.1111.

ADUS has been the subject of a number of research reports. Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Barclays upped their price objective on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research report on Tuesday, November 4th. TD Cowen raised their target price on Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. BMO Capital Markets started coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price target for the company. Finally, UBS Group assumed coverage on shares of Addus HomeCare in a research note on Tuesday, September 2nd. They issued a “buy” rating and a $145.00 price objective on the stock.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the transaction, the executive vice president directly owned 44,144 shares in the company, valued at approximately $4,811,696. This trade represents a 31.18% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold 20,316 shares of company stock valued at $2,215,998 in the last 90 days. 4.50% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Addus HomeCare

Institutional investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. raised its position in shares of Addus HomeCare by 10.1% during the second quarter. Russell Investments Group Ltd. now owns 55,900 shares of the company’s stock valued at $6,439,000 after buying an additional 5,110 shares during the last quarter. Nordea Investment Management AB grew its stake in Addus HomeCare by 0.3% during the second quarter. Nordea Investment Management AB now owns 36,159 shares of the company’s stock valued at $4,131,000 after acquiring an additional 111 shares in the last quarter. Creative Planning increased its holdings in Addus HomeCare by 150.9% in the 2nd quarter. Creative Planning now owns 7,024 shares of the company’s stock valued at $809,000 after acquiring an additional 4,224 shares during the last quarter. Maryland State Retirement & Pension System lifted its stake in Addus HomeCare by 1.9% in the 2nd quarter. Maryland State Retirement & Pension System now owns 5,335 shares of the company’s stock worth $615,000 after purchasing an additional 101 shares in the last quarter. Finally, Loomis Sayles & Co. L P boosted its holdings in shares of Addus HomeCare by 25.2% during the 2nd quarter. Loomis Sayles & Co. L P now owns 101,705 shares of the company’s stock valued at $11,715,000 after purchasing an additional 20,479 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Price Performance

ADUS opened at $113.49 on Wednesday. The company’s 50-day simple moving average is $115.87 and its two-hundred day simple moving average is $113.84. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market capitalization of $2.10 billion, a P/E ratio of 24.30, a P/E/G ratio of 1.54 and a beta of 0.94. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 3rd. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.53 by $0.03. The firm had revenue of $362.30 million during the quarter, compared to analysts’ expectations of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. During the same period in the previous year, the company earned $1.30 earnings per share. The firm’s quarterly revenue was up 25.0% on a year-over-year basis. As a group, analysts predict that Addus HomeCare will post 4.59 EPS for the current year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.